As GLP-1 medications continue to reshape how consumers approach food, nutrition is emerging as a critical companion to pharmaceutical intervention. In a recent Nutrition Insight feature, experts from UC Davis, Fonterra, Ingredion, and Carbery discussed how growing adoption of GLP-1 therapies is accelerating demand for nutrient-dense foods that support satiety, muscle maintenance, digestive health, and overall metabolic wellness. The article highlights a broader shift toward delivering “more nutrition per bite” as consumers seek foods that provide meaningful nutritional value in smaller portions.
Representing the UC Davis Innovation Institute for Food and Health, Kim Fisher emphasized that medication alone is not enough to achieve long-term health outcomes. As GLP-1 therapies become more accessible, Fisher noted the need for stronger integration of nutrition guidance, food innovation, and consumer education. She highlighted an opportunity for the food system to develop healthier, evidence-based options that benefit not only GLP-1 users but the broader population. The discussion reinforces IIFH’s mission of connecting scientific research, industry innovation, and commercialization to address emerging health challenges and create food solutions that support healthier lives at scale.
